Elazer R. Edelman (Professor in Medical Engineering and Science at MIT and Professor of Medicine at Harvard Medical School)

Recent transformative advances in cardiovascular care are remarkable not only for their dramatic impact on mortality and morbidity, nor solely for the rapid expansion of technical innovation, but for the way in which scientific insight and technological capability have continuously propelled one another. Few areas illustrate this co-evolution more clearly than cardiovascular medicine, where engineering principles have become inseparable from biological discovery and clinical progress.

Paradoxically, this tight coupling between theory and application arrived relatively late in medicine. The science of continuum dynamics—the study of how matter and energy deform, flow, and interact across space and time when treated as continuous fields—was foundational to revolutions in physics and chemistry at the turn of the twentieth century, and profoundly influenced art, architecture, design, philosophy, and literature. Biology would follow, but medicine, and cardiovascular medicine in particular, only fully embraced this framework decades later.

Once it did, the consequences were profound—especially for cardiovascular science and biomedical engineering. As the heart came to be understood not merely as an assembly of components or a syncytium of cells, and blood vessels not as passive conduits, but rather as a coupled, multiscale continuum with rich metabolic and synthetic capacity, innovation accelerated, health outcomes improved, and scientific understanding advanced at an unprecedented pace.

This talk will explore how viewing vascular and endothelial biology through a continuum lens has catalyzed new areas of biomedical science and engineering, enabling models, devices, technologies, and therapeutic strategies that have reshaped cardiovascular medicine and human health in ways that are difficult to parallel in any other field.

Elazer R. Edelman is Professor in Medical Engineering and Science at MIT, and Professor of Medicine at Harvard Medical School, and a cardiac intensive care unit cardiologist at the Brigham and Women’s Hospital (BWH). His research interests meld his medical and scientific training leveraging pathophysiologic insight to improve clinical decision-making, materials: tissue biology and device design. More than 400 students and fellows have passed through Edelman’s laboratory publishing over 900 scientific articles and 120 patents that have been the basis of many companies and clinical products.

Edelman is fellow of American College of Cardiology, American Heart Association, Association of University Cardiologists, American Society of Clinical Investigation, American Institute of Medical and Biological Engineering, American Academy of Arts and Sciences, National Academy of Inventors, National Academy of Medicine, and National Academy of Engineering. As Chief Scientific Advisor of Science: Translational Medicine he has set the tone for the national debate on translational research and innovation. As co-founder of ASTM F04.03 he helped create standards for cardiovascular implants. He served on FDA’s Science Board and as ORISE fellow FDA EIR. For bringing cardiovascular translational research to an international level of excellence the Spanish Parliament and King awarded Edelman the Spanish Order of Civil Merit.